SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress
JANESVILLE, Wis., March 18, 2024 /PRNewswire/ -- SHINE Technologies, a leader in medical isotope production, will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile. Attendees are invited to visit Booth A13 to learn about SHINE's production capabilities at its Cassiopeia facility.
- JANESVILLE, Wis., March 18, 2024 /PRNewswire/ -- SHINE Technologies, a leader in medical isotope production, will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile.
- Lu-177.
- Lu-177.
- SHINE invites attendees to visit Booth A13 to learn more about its industry-leading production capabilities for n.c.a Lu-177.